Cure HHT is a non-profit organization dedicated to raising awareness and funding research for Hereditary Hemorrhagic Telangiectasia (HHT), a rare genetic condition that causes abnormal blood vessel formation. The organization aims to empower patients and their families by providing vital resources, education, and support services while advocating for advancements in medical treatment and research efforts. Through community-focused initiatives, including educational programs, national patient conferences, and collaboration with healthcare professionals, Cure HHT strives to enhance the quality of life for those affected by this condition. Their commitment to fostering a supportive community and promoting legislative advocacy reflects their mission to transform lives impacted by HHT.